2023 Vaccine Industry Excellence Best Clinical Trial Company

View Current Trials

Rochester Clinical Research has been proudly conducting clinical research studies in Rochester, New York and the five surrounding counties for over two decades. We are constantly growing our volunteer database, and have completed over 1,000 studies. RCR is an industry leader, winning the 2023 Vaccine Industry Excellence (VIE) Award of Best Clinical Trial Company. We work every day towards medical advancements and changing people’s lives.

RCR Team

Current Clinical Trials

Want to participate in Clinical Research but don’t see a study that fits you today?

Contact us to be added to our database and you’ll be first to know about our future studies.

Sign up for Future Trials

Our Mission

  • Icon: Quality Care
    Quality Care

    At Rochester Clinical Research, we strive to provide every volunteer with the best care. Our friendly, experienced, and knowledgeable staff members make sure that each patient is informed, comfortable, and satisfied with their participation in clinical research.

  • Icon: Quality Data
    Quality Data

    Accurate, accountable, and always working to be better. RCR ensures that protocols are executed correctly, deviations and errors are minimized, and all sponsor needs are met or exceeded timely and efficiently.

  • Icon: Quality Team
    Quality Team

    Our staff is held to the highest standards, beginning with the hiring process, throughout training and onboarding, and consistently through employee tenure. We have developed onsite trainings, and conduct annual boot camps. We support our staff in learning and providing excellent care for our volunteers while executing accurate and timely data collection for our sponsors.

Testimonials

Meet Gayle! As a long time sufferer of migraines, Gayle participated in a migraine study conducted by RCR.

Learn More About Gayle

Other Testimonials

“Your research nurses always took time to explain questions, or just chat a bit. Dr. D. was warm, friendly and caring, and your lab person is excellent–never any bruises! Thanks.”

M.L.S., Henrietta, NY

“I’m very happy for the first time in a year to be relieved of pain and swelling—I feel as if I’ve gotten my active life back!”

G.A., Ontario, NY

“I want to thank you for letting me be in your arthritis study, and for good medicine, and the best of medical care. In fact, your two doctors are better than my own personal physician. Thanks for taking such good care of me. ”

T.D., Rochester, NY

“Barb was thorough in explaining procedures, etc., and she was very accommodating, working around a vacation. I learned a lot about myself, my sleeping patterns–a great experience.”

D.D., Rochester, NY

About RCR’s free Diabetes Self Management Program: “It covered many aspects of the disease, very informative and many hand-outs for use later. Instructors were very knowledgeable and willing to share their ideas and know-how.”

Anonymous
View More

From the RCR Blog

  • Rochester Clinical Research Wins “Best Clinical Trial Site Company” At The 2023 World Vaccine Congress Awards!

    Posted on May 9, 2023

    Rochester Clinical Research is thrilled to announce that we have been awarded the Vaccine Industry Excellence (VIE) award for “Best Clinical Trial Site Company” at the 2023 World Vaccine Congress, which took place on April 4th in Washington, D.C. The VIE Awards is an annual event that celebrates the outstanding achievements made globally by clinical […]

    Read More

  • RCR Helps Acute Migraine Nasal Spay Get FDA Approved

    Posted on May 8, 2023

    Rochester Clinical Research takes great pride in its contribution to Pfizer’s groundbreaking study on Zavzpret (zavegepant) migraine nasal spray, which has recently received FDA approval. This innovative treatment is the first of its kind designed to treat acute migraines in adults by acting as a calcitonin gene-related peptide (CGRP) receptor antagonist, effectively inhibiting CGRP from […]

    Read More

  • RCR’s, Dr. Matthew Davis, on Channel 10 News talking about our pediatric Lyme Disease study

    Posted on April 27, 2023

    Doctors working to develop a vaccine for Lyme Disease Patrick Moussignac News10NBCApril 26, 2023 – 5:56 PM ROCHESTER, N.Y. – Lyme disease is one of the most common diseases transmitted by an insect bite. Doctors say it’s prevalent here in western New York, and no one is immune. There are also no vaccines for it.   Rochester […]

    Read More

Want to participate in Clinical Research?

Contact us to be added to our database and you’ll be first to know about our future studies that may be right for you.

Sign Up Now